Abstract: Attested identities are provided. An applicant requests an attested identity. Attesting resources provide assertions that include roles, rights, and privileges for the attested identity. The collection of assertions from each of the attesting resources represents the attested identity.

Abstract: A method for fabricating a component using a tool includes determining an actual property of a region of the component, comparing the actual property of the region of the component with an expected property of the region to determine a difference between the actual property and the expected property, and updating a path of the tool that is electronically stored in a memory and executable by a processor for fabricating the component based on the difference between the actual property and the expected property of the region.

Abstract: A shock absorber leash incorporates grasping, attaching and elongated strap assemblies. The latter incorporates a strap subassembly, having a strap of non elastic, continuous structure for connecting the grasping and attaching assemblies, and a resilient, adjustable in length subassembly including an elastic strip having its ends attached to a cam-buckle for adjusting a length of the elastic strip. The resilient, adjustable in length subassembly is interposed laterally between the ends of a segment of the strap. The segment is provided adjacent to its ends with a first and second rings and forms a loop when the resilient, adjustable in length subassembly is not completely stretched. The latter is detachable from a remaining of the shock absorber leash by means of the cam-buckle and a free passage of the elastic strip through the first and second rings.

Abstract: Techniques for providing role-based security with instance-level granularity are provided. A security service detects a request made by a principal for access to a resource. Access to the resource is conditioned on a status of a role. The role is associated with the request, the principal, and the resource. The security service evaluates a constraint associated with the role to determine the status. The status is subsequently consumed to determine whether access to the resource for the purposes of satisfying the request is permissible.

Abstract: Techniques for debugging applications are provided. Access to an application is controlled by a wrapper. The wrapper intercepts calls to the application and records the calls. The calls are then passed to the application for processing. The recorded calls form a log which may be analyzed or mined to detect error conditions or undesirable performance characteristics associated with the application independent of source associated with the application.

Abstract: Techniques for the transparent takeover of network connections are presented. A first server is engaged in a connection with a client. The transactions of the connection and the traffic are monitored by a traffic cache manager. The first server records sequence numbers for the transactions with a synchronization store. If the first server fails, a last recorded sequence number is updated by the traffic cache manager within the synchronization store on behalf of a second server, which is to takeover the connection for the unresponsive first server.

Abstract: A formulation and method for the preparation of topical anesthetics formulations, containing one or more anesthetics, in a delivery vehicle designed to promote penetration of the anesthetics into the skin and underlying tissue and to facilitate the speed of action and prolonged response. The stratum corneum layer of the skin at the application site is at least partially removed by an abrading substance, such as pumice, preferably incorporated into the formulation, or by a step that uses a mechanical abrasion of the outer layer of skin, such as a rotating or vibrating brush. The enhanced penetration into the live skin tissue is achieved by removing the outer layer of stratum corneum skin tissue by including an abrading substance in a formulation containing the anesthetics, then rubbing the formulation into the skin, or the use of a brush-like device to assist in the removal of the skin layer.

Abstract: Techniques for distributed workflow processing are presented. A first workflow system and a second workflow system process actions of a workflow. The workflow is coordinated through one or more identity services. The identity services also establish trusted and secure communications between the first and second workflow systems.

Abstract: A method of obtaining data useful for one or more network applications is described. The method is performed responsive to a triggering event, such as a dropped call, a position fix, or even expiration of a timer. A position estimate for a subscriber station is obtained responsive to the event. A record is then formed associating the position estimate for the subscriber station with an identifier of the triggering event and/or data measured or obtained responsive to the event, such as the strength of one or more pilots visible to the subscriber station. The record is either stored locally or transmitted to a remote location. In one implementation, the record is transmitted to a remote location, and stored in a database holding like records relating to other subscriber stations.

Abstract: Methods and systems are provided for trusted key distribution. A key distribution or an identity service acts as an intermediary between participants to a secure network. The service provisions and manages the distribution of keys. The keys are used for encrypting communications occurring within the secure network.

Abstract: This invention describes the simultaneous or sequential administration of therapeutic or diagnostic agents using different devices in combination with a chemical formulation that incorporates or uses vasomodulatory chemical agents as part of the drug delivery vehicle. Methods include the addition of various vasodilatory and vasoconstrictive agents to enhance the systemic or localized tissue delivery of therapeutic or diagnostic agents delivered into a body through the use of an apparatus or device.

Abstract: An Internet Box Office (IBO) system and technique vends digital content via a computer network, such as the Internet. The IBO system comprises a viewing system that cooperates with a Digital Rights Management system and various deployment enhancements within the Internet to provide an infrastructure that facilitates access to digital content in a manner that comports with copyright law and the control of intellectual property by the copyright owner. The IBO system enables a content copyright owner to retain control of its intellectual property while allowing a consumer to have transparent access to the copyright-protected content via the network. To that end, the IBO system operates to download and stage the copyrighted digital content on the viewing system of a consumer.

Abstract: Techniques are provided for allocating resources over a network. A resource consumer requests access to a resource over a network. As part of that request, the resource consumer acquires information that permits it to securely communicate with a resource provider. The resource provider controls the resource and once satisfied with the security of a request from a resource consumer allocates the resource for access by the resource consumer.

Abstract: A noninvasive technique that can be used to deny blood flow to a particular region of tissue, without the inherent risks associated with invasive procedures such as surgery and minimally-invasive procedures such as embolization. Blood flow in selected portions of the vasculature can be occluded by selectively treating specific portions of the vasculature with high intensity focused ultrasound (HIFU). The occlusion denies undesired tissue the nutrients and oxygen provided by blood flow, causing necrosis in the undesired tissue. An imaging technology (such as magnetic resonance imaging, magnetic resonance angiography, ultrasound imaging, Doppler based ultrasound imaging, or computed tomographic angiography) is used to identify the undesired tissue, and the vascular structures associated with the undesired tissue.

Abstract: Techniques are provided for establishing privileged paths for data packets over a network. A data packet is received with a header; the header includes a route selector. The route selector assists in resolving a privileged path for the data packet. The data packet is injected into the network over the resolved privileged path.

Abstract: Techniques are provided for the delivery of client services and for the establishment of client processing environments. A client receives services within a processing environment which is defined by a processing container. The processing container includes one or more processing groups, and each processing group has a particular context that supports one or more applications or services which are processing within that context. The processing groups communicate with one another via connector interfaces included within the processing container. Services and processing containers can be dynamically added or removed from the processing container.

Abstract: A method and apparatus for allowing a transparent service option transition between at least two wireless communication devices (WCDs). A first communication between a first WCD and a second WCD is established using a first service option. At some point during the first communication, a transition to a second service option, such as an asynchronous data service option, is initiated. At least one of the WCDs provides an identification code to the other WCD using a signaling protocol over the first service option. The first communication is then terminated. A second communication using the second service option is then initiated by one of the WCDs, resulting in a seamless transition to the second service option.

Abstract: Topical drug delivery formulations with optical amounts of vasodilator. Vasodilator chemicals applied topically dilate the blood vessels in the skin tissue, which have been shown to facilitate or inhibit systemic or skin tissue deposition of drug substances. The level of stimulation and/or inhibition has been found to be dependent on the concentration and the identity of the specific vasodilator chemical(s) used as well as the drug molecule(s) to be delivered. This work teaches the need to consider specific formulation requirements when dealing with vasodilator chemicals for the creation of successful delivery vehicles in the transdermal drug delivery system. These requirements for very low concentrations of vasodilators were an unexpected and a surprise finding, in contrast to the concentrations of the vasodilators typically used to elicit an increase in skin blood flow.

Abstract: A method for determining and demonstrating the role of vasodilator chemical agents in the development and practice of transdermal drug delivery systems. Vasodilator chemicals applied topically dilate the blood vessels in the skin tissue, which have been shown to facilitate or inhibit systemic or skin tissue deposition of drug substances. The level of stimulation and/or inhibition has been found to be dependent on the concentration and the identity of the specific vasodilator chemical(s) used as well as the drug molecule(s) to be delivered. This work teaches the need to consider specific formulation requirements when dealing with vasodilator chemicals for the creation of successful delivery vehicles in the transdermal drug delivery system. These requirements for very low concentrations of vasodilators were an unexpected and a surprise finding, in contrast to the concentrations of the vasodilators typically used to elicit an increase in skin blood flow.

Abstract: A system for the delivery of chemical vasodilators into the skin for the purpose of increasing the blood flow in a tissue that exhibits compromised circulation. The designated purpose of this increased blood flow is to transiently reverse or inhibit or prevent the onset of an associated medical affliction that may in part or in whole, be either the consequence of that medical condition or participating in the clinical symptoms and etiology of that medical condition. The process and the effect of the topical delivery of a chemical vasodilator has been previously demonstrated for other medical and pharmaceutical applications, however the specific use of this class of drug molecules for the focused effect of improving blood flow to the skin and surrounding tissue with the goal of improving the metabolic health of the tissue and to possibly affect the symptoms of a medical condition is the specific aim of this patent.